- 1. 2,4,D/2,4,5,T
- [(2,4-dichlorophenoxy)acetic acid, butyl ester, mixture with butyl (2,4,5-trichlorophenoxy)acetate; an herbicide and chemical defoliant. ( CSP )] (UMLS (NCI) C0050961) =Organic Chemical; Hazardous or Poisonous Substance =herbicide;
| - 11. DTC 101
- (UMLS (NCI) C1328677) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 2. 6-D-Tryptophan-, 4,4'Mmethylenebis(3-hydroxy-2-naphthalenecarboxylate) (Salt)
- [The pamoate salt of triptorelin, a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion after prolonged administration. After chronic, continuous administration, a sustained decrease in LH, FSH and testicular and ovarian steroidogenesis is observed. The serum testosterone concentration may fall to levels typically seen in surgically castrated men. (NCI04) ( NCI )] (UMLS (NCI) C1137102) Pamorelin;
Triptorelin Pamoate;
TRIPTORELIN PAMOATE UNIDENTIFIED;
TRIPTORELIN PAMOATE PREPARATION;
TRIPTORELIN PAMOATE UNIDENTIFIED =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =6-D-Tryptophan-LH-RH;
Unclassified Ingredients =TRIPTORELIN PAMOATE 11.25 MG | - 12. DTI-015
- (UMLS (NCI) C1328663) =Organic Chemical; Pharmacologic Substance
|
- 3. 6-D-Tryptophan-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Swine)
- [A synthetic nonapeptide analogue of the natural gonadotrophin releasing hormone (GnRH) with potential antineoplastic activity. Deslorelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. Continuous, prolonged administration of goserelin in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. (NCI04) ( NCI )] (UMLS (NCI) C0083220) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 13. DTIC-Dome
- (UMLS (NCI) C0699717) =Organic Chemical; Pharmacologic Substance ;
|
- 4. 6-D-Tryptophan-LH-RH
- [A hormonal anticancer drug that belongs to the family of drugs called gonadotropin-releasing analogues. ( NCI )] (UMLS (NCI) C0077275) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =[AN500] ANTINEOPLASTIC HORMONES;
Unclassified Ingredients =6-D-Tryptophan-, 4,4'Mmethylenebis(3-hydroxy-2-naphthalenecarboxylate) (Salt) | - 14. dTMP kinase
- [ ] (UMLS (CSP) C0058778) =Amino Acid, Peptide, or Protein; Enzyme =other phosphotransferase;
|
- 5. d4T/IFN-A/RIT
- (UMLS (NCI) C0393064) =Therapeutic or Preventive Procedure
| - 15. dTMP Synthase
- [Human thymidylate synthetase protein (312 aa, 36 kDa) is encoded by the human (TYMS) gene. The protein is a conserved transferase enzyme that catalyzes methylene tetrahydrofolate (MTHF)/dUMP conversion to dihydrofolate/dTMP in thymidine triphosphate/deoxyribonucleotide biosynthesis. Thymidylate synthetase competes with the methylene tetrahydrofolate receptor for MTHF and maintains the dTMP pool for DNA replication and repair. ( NCI )] (UMLS (NCI) C0040085) =Amino Acid, Peptide, or Protein; Enzyme ;
=EC 2.1.1;
|
- 6. dT
- [pyrimidine nucleoside, thymine linked by its N1 nitrogen to C1 carbon of ribose. ( CSP )] (UMLS (NCI) C0040077) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=deoxyribonucleoside;
pyrimidine nucleoside =3'-Azido-3'-deoxythymidine;
2'-Deoxy-5-trifluoromethyluridine;
3'-Azido-3'-deoxythymidine;
1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine | - 16. DTP
- [diphtheria, tetanus toxoids and pertussis vaccine ( HL7V3.0 )] (UMLS (HL7) C0012559) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 7. DT (pediatric)
- [diphtheria and tetanus toxoids, adsorbed for pediatric use ( HL7V3.0 )] (UMLS (HL7) C0694727) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 17. DTP-DPP
- [A lipophilic disaccharide derivative of muramyl dipeptide (MDP) with strong immunostimulating activity and used as a vaccine adjuvant. MDP, a component of bacterial cell wall, is the minimum chemical structure required for macrophage activation. Due to MDP's toxicity and short duration of action, theramide was developed with improved stability, and can be administered without a liposome carrier. Theramide stimulates macrophage activity, which in turn potentiates other immune responses, including the release of proinflammatory interleukins and tumor necrosis factor alpha (TNF alpha). The release of these cytokines further augments the activation of cellular and humoral immune system. ( NCI )] (UMLS (NCI) C0281665) =Organic Chemical; Pharmacologic Substance
|
- 8. DTaP
- [diphtheria, tetanus toxoids and acellular pertussis vaccine ( HL7V3.0 )] (UMLS (HL7) C0694728) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 18. DTP-Hib
- [DTP-Haemophilus influenzae type b conjugate vaccine ( HL7V3.0 )] (UMLS (HL7) C0694730) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 9. DTaP, 5 pertussis antigens
- (UMLS (HL7) C1548471) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
| - 19. DTP-Hib-Hep B
- (UMLS (HL7) C1548467) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
|
- 10. DTaPHib
- [DTaP-Haemophilus influenzae type b conjugate vaccine ( HL7V3.0 )] (UMLS (HL7) C0694729) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 20. DTPA/IFN-A/MOAB CC49
- (UMLS (NCI) C0338351) =Therapeutic or Preventive Procedure ;
|
home
